Dr. Maud Kamal, of Institut Curie, joined us for our Virtual Panel Series discussions on November 12, 2020, to discuss using Molecular and Virtual Molecular Tumour Boards to enable Personalised Treatment Decisions.
In this clip, Dr. Kamal discusses advancing Precision Medicine to make better medicine and treatments for all patients.
“We’ve seen that in the last few years that Precision Oncology is moving beyond specific indication and beyond specific cancer types.”
If you would like to watch the full session, visit our events page here.
